• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Webster Capital-backed Discovery Behavioral Health acquires Ambrosia Treatment Center NJ

Share:

December 3, 2018

Webster Capital-backed Discovery Behavioral Health, a behavioral health provider, acquired Ambrosia Treatment Center NJ. Ambrosia provides addiction treatment to patients from the greater Philadelphia and southern New Jersey areas. Ambrosia will operate under the name Pinelands Recovery Center of Medford.

Press Release

Discovery Behavioral Health, a portfolio Company of Webster Capital, is pleased to announce its acquisition of Ambrosia Treatment Center NJ (“Ambrosia”), a behavioral health provider of substance abuse and addiction treatment in New Jersey. Ambrosia primarily treats patients from the greater Philadelphia and Southern New Jersey areas and provides services to patients through an outpatient facility and residential treatment facility. This acquisition does not involve any operations outside New Jersey that operate under the name Ambrosia. Subsequent to transaction close, Ambrosia Treatment Center NJ will operate under the name Pinelands Recovery Center of Medford.

Discovery Behavioral Health is a leading behavioral health provider specializing in the evidence-based treatment of alcohol and drug addiction, eating disorders, and a broad array of mental health conditions. DBH operates more than 65 facilities nationwide and provides the full continuum of care including outpatient, intensive outpatient, partial hospitalization/day treatment, residential treatment, and inpatient detox. Under Webster’s ownership, DBH has rapidly expanded its national footprint and is now one of the largest behavioral health providers in the United States.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Discovery Behavioral Health CEO, John Peloquin, said, “Ambrosia has a reputation of delivering exceptional patient care and we are excited to provide a broader array of behavioral health services to an underserved population. New Jersey and Pennsylvania are among the states most seriously affected by the opioid epidemic. Our combined team is comprised of talented and compassionate industry professionals who share the same core values of quality care and 24/7 family support. By combining the latest advancements in addiction medicine with concierge clinical care, we strive to ensure real progress every single day.”

Ambrosia Founder/CEO Jerry Haffey said, “Ambrosia is dedicated to delivering quality patient care to those struggling with drug and alcohol addiction. We look forward to continued partnerships with quality facilities like Discovery Behavioral Health to help combat this menacing epidemic.”

Cain Brothers, a division of KeyBanc Capital Markets, served as the investment banker on this transactions, and Goodwin Procter LLP acted as legal counsel to Discovery Behavioral Health and Webster Capital.

Date: December 3, 2018

Source: The PE Hub Network

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Breathtec to Open New Drug Development Division, Signs LOI to acquire 100% of Clinical Stage Nash Pharmaceuticals Inc.Breathtec to Open New Drug Development Division, Signs LOI to acquire 100% of Clinical Stage Nash Pharmaceuticals Inc.
  • Will AI Make Clinical Trials Faster & More Efficient?Will AI Make Clinical Trials Faster & More Efficient?
  • Healthcare Blockchain Startup BurstIQ Nabs $5.5M For HIPAA-Compliant Blockchain PlatformHealthcare Blockchain Startup BurstIQ Nabs $5.5M For HIPAA-Compliant Blockchain Platform
  • Sheba Medical Center aims to become world’s 1st VR-based hospitalSheba Medical Center aims to become world’s 1st VR-based hospital
  • Understanding the Third Wave of AI in Healthcare and Life SciencesUnderstanding the Third Wave of AI in Healthcare and Life Sciences
  • Canopy Growth issues shares to acquire stake in Manitoba retail businessCanopy Growth issues shares to acquire stake in Manitoba retail business
  • Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition CorpVisiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp
  • Microsoft delves deeper into IoT with Express Logic acquisitionMicrosoft delves deeper into IoT with Express Logic acquisition

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications